Home068270 • KRX
add
Celltrion Inc
Previous close
₩202,000.00
Day range
₩194,800.00 - ₩201,500.00
Year range
₩131,000.00 - ₩241,000.00
Market cap
42.28T KRW
Avg Volume
641.92K
P/E ratio
94.85
Dividend yield
0.26%
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 874.74B | 66.94% |
Operating expense | 295.34B | 216.97% |
Net income | 78.01B | -47.11% |
Net profit margin | 8.92 | -68.31% |
Earnings per share | 377.00 | -63.54% |
EBITDA | 204.70B | -14.53% |
Effective tax rate | 24.71% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.03T | 53.19% |
Total assets | 20.13T | 220.09% |
Total liabilities | 3.13T | 65.33% |
Total equity | 16.99T | — |
Shares outstanding | 206.33M | — |
Price to book | 2.47 | — |
Return on assets | 0.90% | — |
Return on capital | 0.94% | — |
Cash Flow
Net change in cash
| (KRW) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 78.01B | -47.11% |
Cash from operations | 293.61B | 3.31% |
Cash from investing | 103.88B | 212.18% |
Cash from financing | -246.57B | -287.43% |
Net change in cash | 157.08B | 22.54% |
Free cash flow | 102.18B | -12.49% |
About
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Wikipedia
CEO
Founded
2002
Website
Employees
2,391
